LENZ Therapeutics, Inc. (LENZ)
3.15
0.00 (0.00%)
USD |
NASDAQ |
Oct 27, 16:00
3.21
+0.06
(+1.90%)
After-Hours: 20:00
LENZ Therapeutics Price to Book Value : 0.4513 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 0.4513 |
| October 26, 2026 | 0.4506 |
| October 23, 2026 | 0.4528 |
| October 22, 2026 | 0.4657 |
| October 21, 2026 | 0.4614 |
| October 20, 2026 | 0.4571 |
| October 19, 2026 | 0.4728 |
| October 16, 2026 | 0.4685 |
| October 15, 2026 | 0.5115 |
| October 14, 2026 | 0.4915 |
| October 13, 2026 | 0.4872 |
| October 12, 2026 | 0.5173 |
| October 09, 2026 | 0.5223 |
| October 08, 2026 | 0.5058 |
| October 07, 2026 | 0.5187 |
| October 06, 2026 | 0.543 |
| October 05, 2026 | 0.5144 |
| October 02, 2026 | 0.513 |
| October 01, 2026 | 0.543 |
| September 30, 2026 | 0.5502 |
| September 29, 2026 | 0.5531 |
| September 28, 2026 | 0.5674 |
| September 25, 2026 | 0.561 |
| September 24, 2026 | 0.533 |
| September 23, 2026 | 0.5388 |
| Date | Value |
|---|---|
| September 22, 2026 | 0.5918 |
| September 21, 2026 | 0.5846 |
| September 18, 2026 | 0.5832 |
| September 17, 2026 | 0.5918 |
| September 16, 2026 | 0.5932 |
| September 15, 2026 | 0.6061 |
| September 14, 2026 | 0.6405 |
| September 11, 2026 | 0.6476 |
| September 10, 2026 | 0.6763 |
| September 09, 2026 | 0.7035 |
| September 08, 2026 | 0.7637 |
| September 04, 2026 | 0.854 |
| September 03, 2026 | 0.8354 |
| September 02, 2026 | 0.8311 |
| September 01, 2026 | 0.7494 |
| August 31, 2026 | 0.7465 |
| August 28, 2026 | 0.7322 |
| August 27, 2026 | 0.6892 |
| August 26, 2026 | 0.6849 |
| August 25, 2026 | 0.6691 |
| August 24, 2026 | 0.6577 |
| August 21, 2026 | 0.6706 |
| August 20, 2026 | 0.6677 |
| August 19, 2026 | 0.705 |
| August 18, 2026 | 0.6835 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Impact BioMedical, Inc. | 2.817 |
| Enveric Biosciences, Inc. | 0.6915 |
| Liquidia Corp. | 20.75 |
| Aquestive Therapeutics, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 2.738 |
Price to Book Value Related Metrics
| PS Ratio | 4.486 |
| PEG Ratio | -0.0067 |
| Price | 3.15 |
| Earnings Yield | -129.6% |
| Market Cap | 98.96M |
| PEGY Ratio | -0.0067 |